Jason Rhodes Insider Trades & Stock Holdings

Dyne Therapeutics, Inc. · Latest filing Jun 29, 2026

Jason Rhodes at Dyne Therapeutics, Inc. has 5 Form 4 trades on file since Jun 23, 2026. Open-market activity: 0 purchases ($0) and 5 sales ($16.36M), net -$16.36M. Latest filing: disposed of 195.43K shares of $DYN on Jun 29, 2026 at $21.14.

Trades on file
5
Open-market bought
$0
Open-market sold
$16.36M
Net open-market
-$16.36M
Latest filing
Jun 29, 2026

All insider trades by Jason Rhodes

DateTicker TypeSharesPriceValue Owned afterΔOwn 1W1M6MRoleFilingStory
$DYN Sell (Open-market sale) 10b5-1 195.43K $21.14 $4.13M +7.4%+18.1% —
$DYN Sell (Open-market sale) 10b5-1 309.27K $21.28 $6.58M +9.1%+22.4% Read
$DYN Sell (Open-market sale) 10b5-1 24.10K $21.10 $508.51K +11.9%+24.4% Read
$DYN Sell (Open-market sale) 10b5-1 95.90K $21.02 $2.02M +7.2%+20.2% Read
$DYN Sell (Open-market sale) 10b5-1 147.76K $21.13 $3.12M +9.6%+17.9% Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Jason Rhodes traded

Frequently asked questions

Has Jason Rhodes been buying or selling stock?

Jason Rhodes has 0 open-market purchases and 5 open-market sales on file, net -$16.36M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Jason Rhodes's latest insider trade?

disposed of 195.43K shares of $DYN on Jun 29, 2026 at $21.14.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text